ketoconazole has been researched along with seocalcitol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bastien, Y; Diamandis, EP; Ho, J; Hudson, TJ; Lin, R; Nagai, Y; Petrecca, K; Sladek, R; Sotiropoulou, G; White, JH | 1 |
Feldman, D; Hsu, JY; Peehl, DM; Seto, E | 1 |
3 other study(ies) available for ketoconazole and seocalcitol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation.
Topics: Biomarkers, Tumor; Calcitriol; Carcinoma, Squamous Cell; Cell Adhesion; Cell Differentiation; Cell Division; Cholecalciferol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immune System; Ketoconazole; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 2002 |
Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cell Division; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Ketoconazole; Male; Prostatic Neoplasms; Steroid Hydroxylases; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vitamin D3 24-Hydroxylase | 2002 |